Jessica Sachs Cogent Biosciences, Inc. (COGT) insider trading activity
Jessica Sachs is Chief Medical Officer of Cogent Biosciences, Inc.. Currently has a direct ownership of 622 shares of COGT, which is worth approximately $4,876. The most recent transaction as insider was on Jun 30, 2022, when has been sold 622 shares (Common Stock) at a price of $7.39 per share, resulting in proceeds of $4,597. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
622
0%
3M change
0%
12M change
Total Value Held
$4,876
JS
Jessica Sachs
Chief Medical Officer
Cambridge, MA